Clinical Research Directory
Browse clinical research sites, groups, and studies.
Epivascular Glia Regression and Macular Pigment Restoration After Faricimab in Diabetic Retinopathy
Sponsor: Federico II University
Summary
The aim of the study is to evaluate in diabetic patients affected by diabetic retinopathy epivascular glia regression and macular pigment restoration after faricimab injection in diabetic retinopathy in a 1 year follow up
Official title: Epivascular Glia Regression and Macular Pigment Restoration After Faricimab in Diabetic Retinopathy: A12 Month Multimodal Imaging Study
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
60
Start Date
2025-01-01
Completion Date
2026-01-01
Last Updated
2026-04-13
Healthy Volunteers
Yes
Conditions
Interventions
Faricimab Injection [Vabysmo]
One group treated with faricimab and the other one treated with Aflibercept
Aflibercept (2.0 mg)
Aflibercept 2 mg intravitreal injection
Locations (1)
University of Naples, Federico II, Napoli, Napoli
Naples, Napoli, Italy